FIELD: nuclear medicine for therapeutic purposes, research studies, and process control. SUBSTANCE: rhenium-188 generator is produced as follows: tungsten oxide target is irradiated by neutrons and dissolved in alkali. Nondissolved sediment is dissolved in hydrogen peroxide. Solution obtained is alkalized to pH=12-14. Alkali solution is cleaned by passing it through column with aluminium oxide in OH- form and acidified with hydrochloric acid solution. Then tungsten-188 is transferred to die by sorption on aluminium oxide in H+ form under transient conditions or under static condition with die carried to column with filtering layer of aluminium oxide in H+ form. Rhenium-188 is eluted by solutions of sodium salts. EFFECT: improved radionuclide purity and volume activity of target radionuclide. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
RHENIUM GENERATOR PRODUCTION PROCESS | 1991 |
|
RU2091878C1 |
METHOD OF PRODUCING TECHNETIUM-99M GENERATOR | 1991 |
|
RU2028679C1 |
METHOD OF PRODUCING RADIONUCLIDE IODINE-125 AS SODIUM IODIDE WITHOUT CARRIER | 1992 |
|
RU2069909C1 |
METHOD OF PRODUCING RADIONUCLIDE IODINE-125 AS SODIUM IODIDE WITHOUT CARRIER | 1992 |
|
RU2069910C1 |
METHOD OF OBTAINING GENERATOR-PRODUCED RHENIUM-188 RADIONUCLIDE | 2011 |
|
RU2481660C1 |
METHOD OF PREPARING SULFUR-35 LABELLED SULFATE | 1995 |
|
RU2092433C1 |
METHOD OF MANUFACTURE OF THE CHROMATOGRAPHIC GENERATOR OF TECHNETIUM-99m FROM IRRADIATED BY NEUTRONS MOLYBDENUM-98 | 2004 |
|
RU2276102C1 |
METHOD OF PRODUCING PHARMACEUTICAL SUBSTANCE BASED ON LUTETIUM-177 FROM YTTERBIUM-176 IRRADIATED IN NEUTRON FLUX | 2023 |
|
RU2823124C1 |
METHOD OF PRODUCING NANOSTRUCTURED TARGET FOR PRODUCTION OF RADIONUCLIDE MOLYBDENUM-99 | 2020 |
|
RU2735646C1 |
METHOD OF DERIVING RADIONUCLIDES OF CARRIER-FREE COBALT-57 | 0 |
|
SU1688719A1 |
Authors
Dates
1997-09-27—Published
1991-11-04—Filed